Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Merck
Moodys
Baxter
AstraZeneca

Last Updated: January 20, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Dengue vaccine

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Dengue vaccine?

Dengue vaccine is an investigational drug.

There have been 9 clinical trials for Dengue vaccine. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2016.

The most common disease conditions in clinical trials are Dengue, Encephalitis, Japanese, and Encephalitis. The leading clinical trial sponsors are Takeda, Duke-NUS Graduate Medical School, and B.P. Koirala Institute of Health Sciences.

There are six US patents protecting this investigational drug and one hundred and fourteen international patents.

Recent Clinical Trials for Dengue vaccine
TitleSponsorPhase
Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in HumansDuke-NUS Graduate Medical SchoolPhase 1
Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in HumansNational University Hospital, SingaporePhase 1
Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in HumansNational University, SingaporePhase 1

See all Dengue vaccine clinical trials

Clinical Trial Summary for Dengue vaccine

Top disease conditions for Dengue vaccine
Top clinical trial sponsors for Dengue vaccine

See all Dengue vaccine clinical trials

US Patents for Dengue vaccine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Dengue vaccine   Start Trial Process for preparing an attenuated tetravalent dengue vaccine Fundacao Butantan (Sao Paulo, BR)   Start Trial
Dengue vaccine   Start Trial Process for preparing an attenuated tetravalent dengue vaccine Fundacao Butantan (Sao Paulo, BR)   Start Trial
Dengue vaccine   Start Trial Inactivated dengue virus vaccine with aluminium-free adjuvant GlaxoSmithKline Biologicals SA (Rixensart, BE)   Start Trial
Dengue vaccine   Start Trial Compositions and methods for rapid immunization against dengue virus Takeda Vaccines, Inc. (Deerfield, IL)   Start Trial
Dengue vaccine   Start Trial Dengue virus vaccine compositions and methods of use thereof Merck Sharp & Dohme Corp. (Rahway, NJ)   Start Trial
Dengue vaccine   Start Trial Mono- or di-substituted indole derivatives as dengue viral replication inhibitors Janssen Pharmaceuticals, Inc. (Titusville, NJ) Katholieke Universiteit Leuven (Leuven, BE)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Dengue vaccine

Drugname Country Document Number Estimated Expiration Related US Patent
Dengue vaccine Argentina 105966 2035-09-08   Start Trial
Dengue vaccine Australia 2016318349 2035-09-08   Start Trial
Dengue vaccine Brazil 102015030332 2035-09-08   Start Trial
Dengue vaccine Chile 2018000609 2035-09-08   Start Trial
Dengue vaccine China 108289945 2035-09-08   Start Trial
Dengue vaccine Colombia 2018003451 2035-09-08   Start Trial
Dengue vaccine Costa Rica 20180202 2035-09-08   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Merck
Harvard Business School
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.